A double-blind, double-dummy, randomised, placebo-controlled, four-way crossover study to investigate the effect of single oral doses of SB-649868 [GSK-649868] and of zolpidem in a model of noise induced situational insomnia in healthy male volunteers

Trial Profile

A double-blind, double-dummy, randomised, placebo-controlled, four-way crossover study to investigate the effect of single oral doses of SB-649868 [GSK-649868] and of zolpidem in a model of noise induced situational insomnia in healthy male volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 24 Aug 2017

At a glance

  • Drugs GSK 649868; Zolpidem
  • Indications Insomnia
  • Focus Therapeutic Use
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 18 Sep 2008 Actual patient number (52) added as reported by ClinicalTrials.gov.
    • 17 Sep 2007 Status changed from recruited to completed.
    • 04 Apr 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top